| 1. |
Kevles, D. J. and Hood, L. (ed.) (1992) The Code of Codes: Scientific and Social Issues in the Human Genome Project, Harvard University Press, Cambridge, MA.
|
| |
| 2. |
Nuremberg Code. (1949) Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law No. 10, vol. 2, U.S. Government Printing Office, Washington, DC.
|
| |
| 3. |
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979) The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research, U.S. Department of Health, Education and Welfare, Washington, DC.
|
| |
| 4. |
United States Department of Energy. (1997) Human Genome Program Report, Part 1: Overview and Progress, U.S. Department of Energy, Germantown, MD.
|
| |
| 5. |
Grody, W. W., Kronquist, K. E., Lee, E. U., Edmond, J., and Rome, L. H. (1993) PCR-based cystic fibrosis carrier screening
in a first-year medical student biochemistry laboratory. Am. J. Hum. Genet.
53, 1352–1355.
|
| |
| 6. |
Giardiello, F. M., Brensinger, J. D., Petersen, G. M., Luce, M. C., Hylind, L. M., Bacon, J. A., Booker, S. V., Parker, R.
D., and Hamilton, S. R. (1997) The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N. Engl. J. Med.
336, 823–827.
|
| |
| 7. |
Grody, W. W. (1999) Cystic fibrosis: Molecular diagnosis, population screening, and public policy. Arch. Pathol. Lab. Med.
123, 1041–1046.
|
| |
| 8. |
Geller, G., Botkin, J. R., Green, M. J., Press, N., Biesecker, B. B., Wilfond, B., Grana, G., Daly, M. B., Schneider, K.,
and Kahn, M. J. E. (1997) Genetic testing for susceptibility to adult-onset cancer: The process and content of informed consent.
JAMA
277, 1467–1474.
|
| |
| 9. |
Holtzman, N. A., Murphy, P. D., Watson, M. S., and Barr, P. A. (1997) Predictive genetic testing: From basic research to clinical
practice. Science
278, 602–605.
|
| |
| 10. |
Task Force on Genetic Testing. (1998) Promoting Safe and Effective Genetic Testing in the United States, Johns Hopkins University Press, Baltimore, MD.
|
| |
| 11. |
American Society of Clinical Oncology. (1996) Statement of the American Society of Clinical Oncology: Genetic testing for
cancer susceptibility. J. Clin. Oncol.
14, 81,730–81,736.
|
| |
| 12. |
National Committee for Clinical Laboratory Standards. (1999) Molecular Diagnostic Methods for Genetic Diseases: Approved Guidelines, National Committee for Clinical Laboratory Standards, Wayne, PA.
|
| |
| 13. |
Shattuck-Eidens, D., Oliphant, A., McClure, M., McBride, C., Gupte, J., Rubano, T., et al. (1997) BRCA1 sequence analysis
in women at high risk for susceptibility mutations: Risk factor analysis and implications for genetic testing. JAMA
278, 1242–1250.
|
| |
| 14. |
Billings, P., Cohn, M., de Cuevas, M., Beckwith, J., Alper, J., and Natowicz, M. (1992) Discrimination as a consequence of
genetic testing. Am. J. Hum. Genet.
50, 476–82.
|
| |
| 15. |
Hudson, K. L., Rothenberg, K. H., Andrews, L. B., Kahn, M. J. E., and Collins, F. S. (1995) Genetic discrimination and health
insurance: An urgent need for reform. Science
270, 391–393.
|
| |
| 16. |
Reilly, P. R. (1998) Rethinking risks to human subjects in genetic research. Am. J. Hum. Genet.
63, 682–685.
|
| |
| 17. |
Botkin, J. R., McMahon, W. M., Smith, K. R., and Nash, J. E. (1998) Privacy and confidentiality in the publication of pedigrees:
A survey of investigators and biomedical journals. JAMA
279, 1808–1812.
|
| |
| 18. |
Byers, P. H. and Ashkenas, J. (1998) Pedigrees—Publish? or perish the thought? Am. J. Hum. Genet.
63, 678–681.
|
| |
| 19. |
Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., and Brody, L. C. (1995) The carrier
frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat. Genet.
11, 198–200.
|
| |
| 20. |
Foster, M. W., Bersten, D., and Carter, T. H. (1998) A model agreement for genetic research in socially identifiable populations.
Am. J. Hum. Genet.
63, 696–702.
|
| |
| 21. |
Juengst, E. T. (1998) Group identity and human diversity: Keeping biology straight from culture. Am. J. Hum. Genet.
63, 673–677.
|
| |
| 22. |
Pembrey, M. E. (1998) In the light of preimplantation genetic diagnosis: Some ethical issues in medical genetics revisited.
Eur. J. Hum. Genet.
6, 4–11.
|
| |
| 23. |
Clayton, E. W., Steinberg, K. K., Khoury, M. J., Thomson, E., Andrews, L., Kahn, M. J. E., Kopelman, L. M., and Weiss, J.
O. (1995) Informed consent for genetic research on stored tissue samples. JAMA
274, 1786–1792.
|
| |
| 24. |
Knoppers, B. M. and Laberge, C. M. (1995) Research and stored tissues: Persons as sources, samples as persons? JAMA
274, 1806–1807.
|
| |
| 25. |
Grody, W. W. (1995) Molecular pathology, informed consent, and the paraffin block. Diagn. Molec. Pathol.
4, 155–157.
|
| |
| 26. |
Grizzle, W., Grody, W. W., Noll, W. W., Sobel, M. E., Stass, S. A., Trainer, T., Travers, H., Weedn, V., and Woodruff, K.
(1999) Recommended policies for uses of human tissue in research, education, and quality control. Arch. Pathol. Lab. Med.
123, 296–300.
|
| |
| 27. |
American Society of Human Genetics. (1996) ASHG Report: Statement on informed consent for genetic research. Am. J. Hum. Genet.
59, 471–474.
|
| |
| 28. |
Merz, J. F., Sankar, P., Taube, S. E., and LiVolsi, V. (1997) Use of human tissues in research: Clarifying clinician and researcher
roles and information flows. J. Invest. Med.
45, 252–257.
|
| |
| 29. |
Grody, W. W. and Watson, M. S. (1997) Those elusive molecular diagnostics CPT codes. Diagn. Mol. Pathol.
6, 131–133.
|
| |
| 30. |
Garrett, C. T. and Ferreira-Gonzalez, A. (1996) FDA regulation of analyte-specific reagents (ASRs): Implications for nucleic
acid-based molecular testing. Diagn. Mol. Pathol.
5, 151–153.
|
| |